GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,638.80p
   
  • Change Today:
    -20.60p
  • 52 Week High: 2,263.00p
  • 52 Week Low: 1,638.60p
  • Currency: UK Pounds
  • Shares Issued: 4,067.35m
  • Volume: 757,374
  • Market Cap: £66,656m
  • RiskGrade: 129

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio Not Available

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
96.19% below the market average96.19% below the market average96.19% below the market average96.19% below the market average96.19% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Chg 3m
71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average
62.5% below the sector average62.5% below the sector average62.5% below the sector average62.5% below the sector average62.5% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
68.66% below the market average68.66% below the market average68.66% below the market average68.66% below the market average68.66% below the market average
83.61% below the sector average83.61% below the sector average83.61% below the sector average83.61% below the sector average83.61% below the sector average
Momentum 20
99.76% below the market average99.76% below the market average99.76% below the market average99.76% below the market average99.76% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin Not Available
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS Not Available
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover Not Available
Operating Profit Loss Not Available

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets Not Available
Cash Not Available

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
75.60% above the market average75.60% above the market average75.60% above the market average75.60% above the market average75.60% above the market average
69.23% above the sector average69.23% above the sector average69.23% above the sector average69.23% above the sector average69.23% above the sector average
Buys 1y
96.28% above the market average96.28% above the market average96.28% above the market average96.28% above the market average96.28% above the market average
95.00% above the sector average95.00% above the sector average95.00% above the sector average95.00% above the sector average95.00% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
84.79% below the market average84.79% below the market average84.79% below the market average84.79% below the market average84.79% below the market average
93.75% below the sector average93.75% below the sector average93.75% below the sector average93.75% below the sector average93.75% below the sector average
Brokers Percent Neutral
72.85% above the market average72.85% above the market average72.85% above the market average72.85% above the market average72.85% above the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,638.80p
Change Today -20.60p
% Change -1.24 %
52 Week High 2,263.00p
52 Week Low 1,638.60p
Volume 757,374
Shares Issued 4,067.35m
Market Cap £66,656m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
35.55% below the market average35.55% below the market average35.55% below the market average35.55% below the market average35.55% below the market average
37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 7
Buy 1
Neutral 13
Sell 0
Strong Sell 1
Total 22
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q2 Q1
Ex-Div 18-Aug-22 19-May-22
Paid 06-Oct-22 01-Jul-22
Amount 16.25p 14.00p

Trades for 09-Aug-2022

Time Volume / Share Price
11:42 950 @ 1,638.80p
11:42 185 @ 1,638.80p
11:42 20 @ 1,639.00p
11:42 81 @ 1,639.00p
11:42 172 @ 1,639.00p

GSK Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page